# Quoin Pharmaceuticals Ltd.: Form SCHEDULE 13D/A, filed Jan 28, 2025

- Company: [Quoin Pharmaceuticals Ltd.](/companies/qnrx.md) (CIK 1671502)
- Form: SCHEDULE 13D/A
- Filed: 2025-01-28
- Accepted by EDGAR: Jan 28, 2025, 16:43 ET
- Period: not reported
- Accession: 0001104659-25-006733
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1671502/000110465925006733/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671502/000110465925006733/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671502/000110465925006733/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-006733. Last ingested by Listed: Nov 6, 2026, 18:24 ET. No prices; not investment advice.